SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-24-001490
Filing Date
2024-05-30
Accepted
2024-05-30 18:09:52
Documents
1
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es240484860_4-eckelman.html 4  
1 OWNERSHIP DOCUMENT es240484860_4-eckelman.xml 4 11024
  Complete submission text file 0000950142-24-001490.txt   12632
Mailing Address C/O INHIBRX, INC. 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Eckelman Brendan P. (Reporting) CIK: 0001766433 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241006989

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

IRS No.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)